# US Blood Collection Market

> US Blood Collection Market Research Report: Size, Share, Trend Analysis By Types (Capillary, Venous, Vacuum), By Product (Blood Collection Devices, Blood Collection Tubes, Needles, And Syringes, Lancets), By Method (Automated, Manual), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.93%
- **2024:** $ 1,257.34 Million
- **2025:** $ 1,331.9 Million
- **2035:** $ 2,370.13 Million
- **Key Players:** Thermo Fisher Scientific (US), Becton Dickinson and Company (US), F. Hoffmann-La Roche Ltd (CH), Grifols S.A. (ES), Abbott Laboratories (US), Siemens Healthineers (DE), Ortho Clinical Diagnostics (US), Bio-Rad Laboratories, Inc. (US), HemoCue AB (SE)

**Report ID:** MRFR/MED/11414-CR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** January 29, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-blood-collection-market-12939

---

## Market Summary

## **US Blood Collection Market Highlighted Trends & Dynamics**

The blood collection market is experiencing a significant surge in demand driven by various factors including the increasing prevalence of chronic diseases, advancements in healthcare infrastructure, and rising awareness about the importance of blood donation and testing. Blood collection plays a crucial role in healthcare, as it is essential for diagnosing and monitoring various medical conditions, conducting transfusions, and supporting medical research. With the global burden of diseases such as cancer, diabetes, and cardiovascular disorders on the rise, there is a growing need for efficient and reliable blood collection systems to support patient care and treatment.

One of the primary drivers of the demand for blood collection products is the increasing prevalence of chronic diseases worldwide. Chronic diseases, such as diabetes, cardiovascular diseases, and cancer, require regular monitoring and management, often involving blood tests to assess disease progression, treatment efficacy, and overall health status. As the incidence of these conditions continues to rise, healthcare providers require reliable and convenient blood collection solutions to meet the growing demand for diagnostic testing and monitoring.

Consequently, the blood collection market is witnessing an increase in the adoption of innovative products and technologies that streamline the collection process, minimize patient discomfort, and ensure accurate test results. Furthermore, advancements in healthcare infrastructure, particularly in emerging economies, are driving demand for blood collection products and services. As countries invest in expanding their healthcare systems and improving access to medical services, there is a growing need for reliable blood collection supplies in hospitals, clinics, and diagnostic laboratories.

Additionally, the increasing focus on preventive healthcare and early disease detection is driving demand for blood collection services in community health centers, wellness clinics, and mobile health units. These developments are creating opportunities for blood collection companies to expand their market presence and cater to the growing needs of healthcare providers and patients. Moreover, rising awareness about the importance of blood donation and testing is contributing to the growth of the blood collection market.

Governments, healthcare organizations, and non-profit organizations are actively promoting blood donation drives and organizing awareness campaigns to educate the public about the critical role of blood in saving lives and supporting medical treatments. As a result, there is a growing pool of voluntary blood donors willing to contribute to blood banks and donation centers, increasing the availability of blood products for transfusions and medical procedures. Additionally, the emphasis on regular health check-ups and preventive screenings is encouraging individuals to undergo routine blood tests, further driving demand for blood collection services.

In addition to traditional blood collection methods, technological advancements are shaping the future of the blood collection market. Automated blood collection systems, such as vacuum blood collection devices and safety-engineered needles, are gaining popularity due to their efficiency, safety, and ease of use. These systems minimize the risk of needlestick injuries, reduce contamination, and improve workflow efficiency in healthcare settings. Furthermore, the integration of digital health technologies, such as mobile apps and cloud-based platforms, is enabling remote blood collection services, home-based testing kits, and personalized healthcare solutions.

These innovations are expanding access to blood collection services, particularly in remote and underserved communities, and empowering individuals to take control of their health.

## Market Drivers

### Growth in Diagnostic Testing

The blood collection market is experiencing growth due to the rising demand for diagnostic testing. As healthcare systems increasingly emphasize preventive care, the need for accurate and timely diagnostic tests has surged. The American Clinical Laboratory Association reports that the diagnostic testing market is projected to reach $85 billion by 2026, with blood tests accounting for a substantial portion of this growth. This trend indicates a robust demand for blood collection services, as healthcare providers rely on these tests to inform treatment decisions. Consequently, the blood collection market is likely to benefit from this expanding landscape, necessitating advancements in collection techniques and technologies.

### Regulatory Support and Standards

Regulatory frameworks and standards play a crucial role in shaping the blood collection market. The US Food and Drug Administration (FDA) and other regulatory bodies establish guidelines that ensure the safety and efficacy of blood collection practices. Recent initiatives aimed at streamlining regulations and enhancing compliance are likely to foster innovation within the industry. By promoting best practices and ensuring high-quality standards, these regulations can enhance public trust in blood collection services. As a result, the blood collection market may experience growth, as healthcare providers seek to align with regulatory expectations while delivering safe and reliable services.

### Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases in the US is a pivotal driver for the blood collection market. Conditions such as diabetes, cardiovascular diseases, and cancer necessitate regular blood testing for monitoring and management. According to the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 adults in the US have a chronic disease, which underscores the demand for blood collection services. This trend is likely to propel the market forward, as healthcare providers require efficient blood collection methods to facilitate timely diagnosis and treatment. The blood collection market is thus positioned to expand, driven by the need for routine blood tests in managing these prevalent health issues.

### Technological Innovations in Blood Collection

Technological advancements are transforming the blood collection market, enhancing efficiency and safety. Innovations such as automated blood collection devices and advanced needle technologies are streamlining the process, reducing patient discomfort, and minimizing the risk of contamination. The integration of digital health solutions, including mobile applications for appointment scheduling and results tracking, is also gaining traction. These innovations not only improve patient experience but also increase the operational efficiency of healthcare facilities. As the blood collection market adapts to these technological changes, it is expected to witness significant growth, driven by the demand for more effective and patient-friendly blood collection methods.

### Increased Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a significant driver for the blood collection market. The US government and private sector are allocating substantial funds to enhance healthcare facilities, particularly in underserved areas. This investment is aimed at improving access to essential services, including blood collection. According to the American Hospital Association, hospitals are projected to invest over $100 billion in capital projects by 2026, which includes upgrading laboratory services. This influx of capital is likely to bolster the blood collection market, as improved infrastructure facilitates better collection practices and expands access to diagnostic testing for a broader population.

## Future Outlook

The [Blood Collection Market](https://www.marketresearchfuture.com/reports/blood-collection-market-7013) is projected to grow at a 5.93% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for blood products, and enhanced healthcare infrastructure.

**New opportunities:**

- Development of mobile blood collection units for remote areas. Integration of AI for predictive analytics in blood demand forecasting. Expansion of partnerships with healthcare providers for streamlined blood collection services.

By 2035, the blood collection market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Vacutainers (Largest) vs. Blood Bags (Fastest-Growing)

In the US blood collection market, the segment distribution is primarily dominated by Vacutainers, which hold the largest market share due to their widespread use and reliability. Syringes and blood collection tubes follow, with significant usage in specific applications, while blood bags are also gaining traction due to the increase in blood donation activities.

The growth trends in this segment are primarily driven by advancements in technology and increasing demand for safe blood collection methods. Blood bags, being the fastest-growing category, benefit from innovations in materials and designs that enhance their usability and safety. The focus on patient safety and regulatory compliance continues to push the development of these blood collection products.

Vacutainers (Dominant) vs. Blood Bags (Emerging)

Vacutainers are widely recognized as the dominant choice in the blood collection segment, primarily attributed to their efficiency and ability to minimize contamination during blood sampling. They are extensively used in laboratories and medical facilities for their reliability and standardization. Conversely, blood bags represent an emerging category fueled by the increasing demand for blood storage solutions as awareness regarding the necessity for blood donations rises. Innovations in blood bag designs, like integrated safety features and improved storage capabilities, cater to evolving market needs, positioning them favorably for future growth in the sector.

### By Method: Automated Blood Collection (Largest) vs. Manual Blood Collection (Fastest-Growing)

In the US blood collection market, the segment distribution showcases Automated Blood Collection as the largest method, maintaining its significant share due to efficiency and demand for high-volume procedures. Meanwhile, Manual Blood Collection is showing promising growth as healthcare providers seek more cost-effective solutions and flexibility in diverse clinical settings.

Growth trends highlight an increasing shift towards technology-driven solutions, particularly in Automated Blood Collection, which benefits from advancements in automation and robotics. Simultaneously, the Manual Blood Collection segment is experiencing a surge due to new regulatory changes and training initiatives that encourage its adoption in outpatient care and rural health applications.

Blood Collection: Automated (Dominant) vs. Manual (Emerging)

Automated Blood Collection is characterized by its ability to process large volumes efficiently, making it the dominant method in the market. Its adoption is driven by hospitals and labs aiming to enhance throughput and accuracy. As automation continues to evolve, reliability and user-friendliness are also being prioritized. In contrast, Manual Blood Collection stands as an emerging choice, particularly in smaller healthcare settings where cost constraints and flexibility are paramount. This method remains essential for diverse blood sampling needs and is supportive of personalized patient care, despite competition from more automated approaches.

### By End Use: Hospitals (Largest) vs. Blood Banks (Fastest-Growing)

In the US blood collection market, hospitals comprise the largest segment, accounting for a significant portion of overall market share. Diagnostic laboratories follow, leveraging advanced technology to streamline testing. Blood banks and home care segments, while smaller, play crucial roles in specialized scenarios, with blood banks seeing a notable alignment with sourcing needs and support from governmental initiatives. 

Growth trends in this market are driven by an increasing demand for blood products and a focus on improving healthcare services. Hospitals continue to invest in cutting-edge blood collection technologies, enhancing their operational efficiencies. Meanwhile, blood banks are rapidly expanding their capabilities and services, responding to the rising need for safe blood supply and facilitating community health programs, thus attracting more investments and innovations.

Hospitals (Dominant) vs. Blood Banks (Emerging)

Hospitals represent the dominant force in the US blood collection market, integrating advanced technologies to enhance efficiency and patient care. They employ systematic collection protocols and have established partnerships with vendors for streamlined processes. Conversely, blood banks are emerging with increased focus on public health partnerships and community outreach, driven by regulatory support and demand for safe blood supply. Blood banks are innovating in collection techniques and donation drives, while hospitals prioritize operational excellence. This dynamic interaction between the two segments is fostering a collaborative landscape where both can thrive and adapt to the evolving healthcare needs.

### By Application: Transfusion (Largest) vs. Diagnostic Testing (Fastest-Growing)

In the US blood collection market, the 'Application' segment is primarily dominated by the transfusion category, which holds the largest market share. Following closely is the diagnostic testing segment, experiencing significant growth due to the increasing demand for accurate and timely medical diagnostics. Research applications, while essential, account for a smaller proportion of the overall market, reflecting a more specialized use of blood collection technologies. 

The growth trends within the application segment indicate a robust movement towards advancements in technologies used for diagnostic testing, propelled by rising healthcare needs and innovations in analysis techniques. Additionally, the transfusion segment is not only foundational but also supported by an aging population and higher incidences of chronic diseases requiring blood transfusions. This interplay helps map the evolving landscape of the US blood collection market.

Transfusion (Dominant) vs. Diagnostic Testing (Emerging)

The transfusion segment stands as the dominant force in the US blood collection market, characterized by well-established protocols and wide acceptance in clinical settings. Its importance is magnified by the critical need for blood products in emergency care and surgical procedures. This established segment ensures steady demand and reliability, making it a focal point for healthcare providers. On the other hand, diagnostic testing represents an emerging facet of the market, fueled by technological innovations and a growing emphasis on preventative healthcare measures. As healthcare providers increasingly prioritize early diagnosis and personalized medicine, the demand for diverse blood tests is expected to surge. This growth presents opportunities for new entrants and technology developers, creating an exciting dynamic within the US blood collection market.

## Competitive Benchmarking

The [blood collection market](https://www.marketresearchfuture.com/reports/blood-collection-market-7013) in the US is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on operational efficiency. Key players such as Thermo Fisher Scientific (US), Becton Dickinson and Company (US), and Abbott Laboratories (US) are at the forefront, leveraging their extensive portfolios and technological advancements to capture market share. These companies are not only enhancing their product offerings but are also investing in digital transformation initiatives to streamline operations and improve customer engagement, thereby influencing the overall competitive dynamics. In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market appears moderately fragmented, with several players vying for dominance. However, the collective influence of major companies like Siemens Healthineers (DE) and Grifols S.A. (ES) is notable, as they implement strategies that enhance their competitive positioning while fostering innovation across the sector. In October 2025, Thermo Fisher Scientific (US) announced a strategic partnership with a leading biotechnology firm to develop next-generation blood collection devices. This collaboration is expected to enhance their product line and address the growing demand for more efficient and user-friendly blood collection solutions. The strategic importance of this partnership lies in its potential to accelerate innovation and expand market reach, positioning Thermo Fisher as a leader in the evolving landscape. In September 2025, Becton Dickinson and Company (US) launched a new line of automated blood collection systems aimed at improving efficiency in clinical settings. This move is significant as it aligns with the increasing demand for automation in healthcare, potentially reducing human error and enhancing patient safety. The introduction of these systems may also strengthen Becton Dickinson's competitive edge by addressing the operational challenges faced by healthcare providers. In August 2025, Abbott Laboratories (US) expanded its blood collection product portfolio by acquiring a smaller firm specializing in innovative blood testing technologies. This acquisition is likely to enhance Abbott's capabilities in the blood collection market, allowing for a more comprehensive suite of products that cater to diverse customer needs. The strategic importance of this acquisition lies in its potential to drive growth and innovation, further solidifying Abbott's position in a competitive market. As of November 2025, current trends in the blood collection market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into operational processes. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and innovative product offerings, reflecting a broader shift in market dynamics.

## Report Scope

| MARKET SIZE 2024 | 1257.34(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1331.9(USD Million) |
| MARKET SIZE 2035 | 2370.13(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.93% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Thermo Fisher Scientific (US), Becton Dickinson and Company (US), F. Hoffmann-La Roche Ltd (CH), Grifols S.A. (ES), Abbott Laboratories (US), Siemens Healthineers (DE), Ortho Clinical Diagnostics (US), Bio-Rad Laboratories, Inc. (US), HemoCue AB (SE) |
| Segments Covered | Type, Method, End Use, Application |
| Key Market Opportunities | Integration of advanced automation and digital solutions enhances efficiency in the blood collection market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and efficiency in the blood collection market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the overall market valuation of the US blood collection market in 2024?**
A: The overall market valuation was $1257.34 Million in 2024.

**Q: What is the projected market valuation for the US blood collection market by 2035?**
A: The projected valuation for 2035 is $2370.13 Million.

**Q: What is the expected CAGR for the US blood collection market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during this period is 5.93%.

**Q: Which companies are considered key players in the US blood collection market?**
A: Key players include Thermo Fisher Scientific, Becton Dickinson and Company, and Abbott Laboratories.

**Q: What are the main segments of the US blood collection market?**
A: The main segments include Type, Method, End Use, and Application.

**Q: What was the market size for blood collection tubes in 2024?**
A: The market size for blood collection tubes was $400.0 Million in 2024.

**Q: How much is the automated blood collection segment projected to grow by 2035?**
A: The automated blood collection segment is projected to grow to $1200.0 Million by 2035.

**Q: What was the market valuation for diagnostic laboratories in 2024?**
A: The market valuation for diagnostic laboratories was $300.0 Million in 2024.

**Q: What is the projected market size for diagnostic testing applications by 2035?**
A: The projected market size for diagnostic testing applications is $1100.0 Million by 2035.

**Q: What was the market size for blood bags in 2024?**
A: The market size for blood bags was $307.34 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-blood-collection-market-12939*